New York City, May 30, 2017 -- Dr. Mark Stein has been named a top oral and maxillofacial surgeon in New York Times Magazine’s first-ever collection of “Super Specialists!” This esteemed list of leading NYC oral surgeons was chosen by their peers after a rigorous selection process. Approximately 5% of New York City’s oral surgeons are named to this list, making it a highly-coveted honor for Dr. Stein.
Dr. Mark Stein has years of experience providing high-level care to oral surgery patients—having placed thousands of dental implants during his career. Dr. Stein combines sophisticated technology with the latest oral surgery innovations to achieve long-lasting results for his patients. His expertise includes dental implants, bone grafting, wisdom teeth extractions, sinus lifts, BOTOX®, and dermal fillers. Dr. Stein is dedicated to ensuring patient satisfaction by providing personalized care for each individual undergoing oral surgery.
New York City’s “Super Specialists” are nominated by colleagues who consider them to be exceptional in their field of oral and maxillofacial surgery. Finalists are chosen after a thorough peer review process that includes a detailed survey, good standing and disciplinary check, and evaluation, as well as extensive independent research on each candidate. Years in practice, fellowships, achievements, awards, board certifications, publications, and presentations are just some of the indicators used to determine the final list of “Super Specialists.” Honorees are considered premier experts in their oral and maxillofacial surgery specialty.
“It’s a great personal achievement,” says Dr. Stein on being named a top oral surgeon by New York Times Magazine. “Being named as a Super Specialist means all the work my team and I do every day to provide the highest level of care to our patients does not go unnoticed. It's also a great honor to be listed alongside Chairmen of Oral & Maxillofacial Surgery Departments of the major NYC teaching institutions.”
Dr. Mark Stein is a leading oral and maxillofacial surgeon serving the New York City area. Dr. Stein graduated from New York University’s College of Dentistry and went on to receive his Medical Degree from Rutgers Medical School and Residency in Oral and Maxillofacial Surgery at the University of Medicine and Dentistry of New Jersey. He is one of a few Oral & Maxillofacial Surgeons to possess both a DDS and a Medical Degree (MD). He has won numerous awards, including the American Association of Oral & Maxillofacial Surgery Outstanding Achievement Award and the top oral surgery prize in the United States for the American Dental Association National Basic Science Competition. Dr. Stein is a proud member of the American Association of Oral Maxillofacial Surgery, the Academy of Osseointegration, and the OKU Honor Society. He is a leading authority in the fields of oral and maxillofacial surgery, having lectured on dental implants, facial reconstruction, and bone grafting. Dr. Stein has also been featured in the Wall Street Journal, Yahoo! Finance, and Google News.
To learn more about undergoing oral surgery with Dr. Mark Stein, you can contact New York Oral & Maxillofacial Surgery by phone at (212) 888-4760 or by requesting an appointment online to schedule your consultation.
For additional information: New York Oral & Maxillofacial Surgery 800A Fifth Avenue, Suite 404 New York, NY 10065 (212) 888-4760


Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case
Pentagon and Anthropic Clash Over AI Safeguards in National Security Use
Amazon Stock Dips as Reports Link Company to Potential $50B OpenAI Investment
Bob Iger Plans Early Exit as Disney Board Prepares CEO Succession Vote
Sandisk Stock Soars After Blowout Earnings and AI-Driven Outlook
Disney Board Nears CEO Decision as Josh D’Amaro Emerges as Leading Candidate
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs
American Airlines Plans Return to Venezuela Flights After U.S. Lifts Ban
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI
OpenAI Reportedly Eyes Late-2026 IPO Amid Rising Competition and Massive Funding Needs
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz 



